Yuji Matsuzawa Selected Research

Syndrome

04/2007	The genes influencing adiponectin levels also influence risk factors for metabolic syndrome and type 2 diabetes.
05/2006	The metabolic syndrome and adipocytokines.
03/2006	Adiponectin: a key adipocytokine in metabolic syndrome.
01/2006	Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease.
02/2005	Adipocytokines and metabolic syndrome.
11/2004	Adiponectin as a biomarker of the metabolic syndrome.
04/2004	Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease.
01/2004	Adiponectin and metabolic syndrome.
06/2003	Disturbed secretion of mutant adiponectin associated with the metabolic syndrome.
11/2002	[Significance of adipocytokine, fat-derived hormones, in metabolic syndrome]
07/2002	Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome.
07/2002	[Adiponectin as a key molecule of the metabolic syndrome]

12	Syndrome 04/2007 - 07/2002
8	Obesity 03/2007 - 04/2002
7	Hypercholesterolemia 08/2008 - 01/2002
6	Insulin Resistance 07/2007 - 07/2002
4	Lipodystrophy 06/2004 - 05/2002
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2008 - 04/2002
3	Atherosclerosis (Atheroma) 01/2005 - 11/2002
3	Hypertension (High Blood Pressure) 03/2004 - 09/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2008 - 01/2006
2	Overweight 12/2005 - 11/2002
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2005 - 01/2002
2	Nephrotic Syndrome (Syndrome, Nephrotic) 08/2003 - 05/2003
1	Stroke (Strokes) 07/2008
1	Type 2 Diabetes Mellitus (MODY) 04/2007
1	Heart Failure 09/2005
1	Adenoma (Adenomas) 05/2005
1	Vascular Diseases (Vascular Disease) 05/2005
1	Arteriosclerosis 03/2004
1	Hepatocellular Carcinoma (Hepatoma) 12/2003
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2003
1	Breast Neoplasms (Breast Cancer) 11/2003
1	Cushing Syndrome 10/2003
1	Carcinoid Tumor (Carcinoid) 10/2003
1	Takayasu Arteritis (Arteritis, Takayasu's) 09/2003
1	Hyperlipoproteinemias 06/2003
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 05/2003
1	Body Weight (Weight, Body) 01/2003
1	Coronary Disease (Coronary Heart Disease) 12/2002
1	Pathologic Constriction (Stenosis) 10/2002
1	Weight Gain 10/2002
1	Meningoencephalitis 05/2002
1	Tissue Adhesions 04/2002
1	Stomach Neoplasms (Stomach Cancer) 04/2002
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2002
1	Fatty Liver 02/2002
1	Esophageal Neoplasms (Esophageal Cancer) 01/2002

35	AdiponectinIBA 04/2008 - 01/2002
6	Simvastatin (Zocor)FDA LinkGeneric 08/2008 - 12/2002
6	AdipokinesIBA 05/2006 - 01/2003
4	CholesterolIBA 08/2008 - 12/2002
4	Lipoproteins (Lipoprotein)IBA 03/2005 - 05/2003
2	C-Reactive ProteinIBA 01/2005 - 03/2004
2	ApolipoproteinsIBA 06/2003 - 11/2002
2	Epidermal Growth Factor (EGF)IBA 04/2002 - 01/2002
1	Eicosapentaenoic AcidIBA 07/2008
1	NeuropeptidesIBA 03/2007
1	secretogranin IIIIBA 03/2007
1	Plasminogen Activators (Plasminogen Activator)IBA 12/2005
1	Glucose (Dextrose)FDA LinkGeneric 09/2005
1	rosiglitazone (Avandia)FDA Link 06/2004
1	Ephrin-B1 (Ephrin B1)IBA 12/2003
1	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2003
1	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2003
1	Matrix MetalloproteinasesIBA 09/2003
1	BezafibrateIBA 08/2003
1	atorvastatin (Lipitor)FDA Link 06/2003
1	imatinib (Gleevec)FDA Link 05/2003
1	HDL CholesterolIBA 01/2003
1	HormonesIBA 11/2002
1	LeptinIBA 05/2002
1	Ganciclovir (Cytovene)FDA LinkGeneric 05/2002
1	heparin-binding EGF-like growth factor (HB-EGF)IBA 04/2002
1	Protein Tyrosine PhosphatasesIBA 04/2002
1	Heparin (Liquaemin)FDA LinkGeneric 04/2002
1	Cyclin D1IBA 02/2002
1	PPAR gammaIBA 02/2002
1	microsomal triglyceride transfer proteinIBA 02/2002
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2002
1	rosuvastatin (Crestor)FDA Link 01/2002

2	Highly Active Antiretroviral Therapy (HAART) 06/2004 - 04/2003
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2002